Search results
Declining Stock and Solid Fundamentals: Is The Market Wrong About Moderna, Inc. (NASDAQ:MRNA)?
Simply Wall St. via Yahoo Finance· 10 months agoWith its stock down 20% over the past three months, it is easy to disregard Moderna (NASDAQ:MRNA)....
Institutional owners may consider drastic measures as Moderna, Inc.'s (NASDAQ:MRNA) recent US$6.3b...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna, Inc. (NASDAQ:MRNA) is favoured by institutional owners who hold 66% of the company
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Given the large stake in the stock by institutions, Moderna's stock price might be...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 1 year agoModerna (MRNA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights The projected fair value for Moderna is US$151 based on 2 Stage Free Cash Flow to...
Institutional investors may adopt severe steps after Moderna, Inc.'s (NASDAQ:MRNA) latest 3.7% drop...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Given the large stake in the stock by institutions, Moderna's stock price might be...
Moderna (NASDAQ:MRNA) shareholders have earned a 36% CAGR over the last five years
Simply Wall St. via Yahoo Finance· 5 months agoIt hasn't been the best quarter for Moderna, Inc. (NASDAQ:MRNA) shareholders, since the share price...
With 66% ownership of the shares, Moderna, Inc. (NASDAQ:MRNA) is heavily dominated by institutional...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Given the large stake in the stock by institutions, Moderna's stock price might be...
Moderna Stock (NASDAQ:MRNA) at $100: Looking Past COVID-19 Vaccines for Profits
TipRanks via Yahoo Finance· 2 months agoPeople depended on Moderna (NASDAQ:MRNA) in 2020 and 2021 for COVID-19 vaccines, but the pharma...
An Intrinsic Calculation For Moderna, Inc. (NASDAQ:MRNA) Suggests It's 46% Undervalued
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights The projected fair value for Moderna is US$241 based on 2 Stage Free Cash Flow to...